Efficacy and Safety of Intravenous Iron Therapy for HCV-Positive Haemodialysis Patients

Publisher： Karger

E-ISSN： 1660-2110|100|3|c78-c85

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.100, Iss.3, 2005-04, pp. : c78-c85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Sevelamer in the Treatment of Uncontrolled Hyperphosphataemia of Haemodialysis Patients

By  

Nephron Clin Pract, Vol. 97, Iss. 1, 2004-11 ,pp. : c17-c22

Karger

Access to resources Recommend Favorite

Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive Patients

By  

Oncology, Vol. 80, Iss. 5-6, 2011-08 ,pp. : 366-372

Karger

Access to resources Recommend Favorite

Assessment of free light chains in HCV‐positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 9, 2015-09 ,pp. : 2100-2107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections

By Aikawa Naoki  

Journal of Infection and Chemotherapy, Vol. 19, Iss. 3, 2013-06 ,pp. : 447-455

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review

By  

AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 58, Iss. 1, 2018-02 ,pp. : 22-39

John Wiley & Sons Inc

Access to resources Recommend Favorite